{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:41:27Z","timestamp":1788280887802,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["F53D23012310001"],"award-info":[{"award-number":["F53D23012310001"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["24449"],"award-info":[{"award-number":["24449"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152633","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:53:46Z","timestamp":1779292426000},"page":"152633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibition of the oncogenic GTPase dynamin-related protein 1 (DRP1) by the FDA-approved drug fosaprepitant: In silico, biophysical, and in vitro characterization of its anti-myeloma activity"],"prefix":"10.1016","volume":"369","author":[{"given":"Emanuela","family":"Marchese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Murfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia Gallo","family":"Cantafio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Alessandra","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giosu\u00e8","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152633_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","article-title":"Molecular mechanisms of mitochondrial dynamics","volume":"26","author":"T\u00e1bara","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211084","article-title":"Mitochondrial quality control and cell death","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0025","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41467-024-45524-4","article-title":"Structural basis for regulated assembly of the mitochondrial fission GTPase Drp1","volume":"15","author":"Rochon","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1091\/mbc.e12-10-0721","article-title":"Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission","volume":"24","author":"Los\u00f3n","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1300855110","article-title":"Interchangeable adaptors regulate mitochondrial dynamin assembly for membrane scission","volume":"110","author":"Koirala","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0040","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/emboj.2013.74","article-title":"Structural insights into oligomerization and mitochondrial remodelling of dynamin 1-like protein","volume":"32","author":"Fr\u00f6hlich","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071835","article-title":"Functional mapping of human dynamin-1-like GTPase domain based on X-ray structure analyses","volume":"8","author":"Wenger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","article-title":"mTOR controls mitochondrial dynamics and cell survival via MTFP1","volume":"67","author":"Morita","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01373","article-title":"mTORC1 as a regulator of mitochondrial functions and a therapeutic target in cancer","volume":"9","author":"De La Cruz L\u00f3pez","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0065","article-title":"Dysregulated mitochondrial dynamics in cancer: unlocking new strategies to combat drug resistance","volume":"1881","author":"Rossi","year":"2026","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12967-023-04498-5","article-title":"Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer","volume":"21","author":"Rocca","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12967-024-05013-0","article-title":"Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity","volume":"22","author":"Torcasio","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0085","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1186\/s12967-025-06942-0","article-title":"Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax","volume":"23","author":"Valentino","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0090","first-page":"16","article-title":"Non-coding RNA-dependent regulation of mitochondrial dynamics in cancer pathophysiology","volume":"9","author":"Gallo Cantafio","year":"2023","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1155621","article-title":"Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment","volume":"13","author":"Matamala Montoya","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12967-024-05013-0","article-title":"Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity","volume":"22","author":"Torcasio","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0105","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.287526","article-title":"Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma","author":"Cantafio","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107574","article-title":"Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells","volume":"150","author":"Sami Alkafaas","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","article-title":"Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization","volume":"14","author":"Cassidy-Stone","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2017.02.020","article-title":"The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex i inhibitor that modulates reactive oxygen species","volume":"40","author":"Bordt","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0125","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1096\/fj.201901467R","article-title":"Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25464-z","article-title":"A novel small molecule inhibitor of human Drp1","volume":"12","author":"Rosdah","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2018.03.189","article-title":"Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1","volume":"499","author":"Mallat","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0140","series-title":"Schr\u00f6dinger Release 2020\u20134: Maestro","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0145","first-page":"67","article-title":"Crystal structure of GTPase domain fused with minimal stalks from human dynamin-1-like protein (Dlpl) in complex with several nucleotide analogues","volume":"14","author":"Kishida","year":"2013","journal-title":"Current Topics in Peptide & Protein Research"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0150","article-title":"Crystal structure of human Dlp1 in complex with GDP.AlF4","author":"Kishida","year":"2014","journal-title":"Worldwide Protein Data Bank"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0155","series-title":"Schr\u00f6dinger Release 2020\u20134: Protein Preparation Wizard","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0165","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0170","series-title":"Schr\u00f6dinger Release 2020-4: Desmond Molecular Dynamics System","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0175","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0180","series-title":"Schr\u00f6dinger Release 2020-4: LigPrep","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0185","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: p K a and Protonation State Prediction through Machine Learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0190","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0195","series-title":"Schr\u00f6dinger Release 2020-4: Glide","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0200","series-title":"Schr\u00f6dinger Release 2018-1: Canvas","year":"2018"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0205","first-page":"20","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0210","series-title":"Schr\u00f6dinger Release 2020-4: Prime","year":"2020"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0220","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/leu.2016.102","article-title":"Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism","volume":"30","author":"Soriano","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0225","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","article-title":"BRD9 degradation disrupts ribosome biogenesis in multiple myeloma","volume":"29","author":"Kurata","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182226","article-title":"GPER1 activation exerts anti-tumor activity in multiple myeloma","volume":"12","author":"Gallo Cantafio","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111639","article-title":"Oleil Hydroxytyrosol (HTOL) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells","volume":"22","author":"Todoerti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0240","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0245","doi-asserted-by":"crossref","first-page":"15289","DOI":"10.1002\/anie.201707682","article-title":"Differential epitope mapping by STD NMR spectroscopy to reveal the nature of protein\u2013ligand contacts","volume":"56","author":"Monaco","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","article-title":"Computational drug repurposing: approaches, evaluation of in silico resources and case studies","volume":"24","author":"Tanoli","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104390","article-title":"Therapeutic innovation in drug repurposing: challenges and opportunities","volume":"30","author":"Recino","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202403434","article-title":"Sulfonamides as a promising scaffold in drug discovery: an insightful review on FDA-approved molecules, synthesis strategy, medical indication, and their binding mode","volume":"22","author":"Aslam","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0265","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41416-023-02502-9","article-title":"Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy","volume":"130","author":"Weth","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0270","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s11684-025-1140-8","article-title":"Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting","volume":"19","author":"Zhu","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0280","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","article-title":"NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007041","article-title":"Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies","volume":"15","author":"Civera","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0290","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/acsmedchemlett.3c00303","article-title":"Identification of HuR\u2013RNA interfering compounds by dynamic combinatorial chemistry and fluorescence polarization","volume":"14","author":"Della Volpe","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0295","doi-asserted-by":"crossref","first-page":"45147","DOI":"10.1021\/acsomega.4c06244","article-title":"Peptide nucleic acids in saturation transfer difference nuclear magnetic resonance experiments: a simple and valuable tool for studying HuR\u2013small molecule complexes","volume":"9","author":"Gado","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0300","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.devcel.2025.07.014","article-title":"Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis","volume":"60","author":"Zheng","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152633_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026025602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026025602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:16:37Z","timestamp":1783156597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026025602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"alternative-id":["S0141813026025602"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152633","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the oncogenic GTPase dynamin-related protein 1 (DRP1) by the FDA-approved drug fosaprepitant: In silico, biophysical, and in vitro characterization of its anti-myeloma activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152633"}}